Literature DB >> 16760404

A mouse model of persistent brain infection with recombinant Measles virus.

S Schubert1, K Möller-Ehrlich1, K Singethan1, S Wiese2, W P Duprex3, B K Rima3, S Niewiesk4, J Schneider-Schaulies1.   

Abstract

Measles virus (MV) nucleocapsids are present abundantly in brain cells of patients with subacute sclerosing panencephalitis (SSPE). This invariably lethal brain disease develops years after acute measles as result of a persistent MV infection. Various rodent models for MV infection of the central nervous system (CNS) have been described in the past, in which the detection of viral antigens is based on histological staining procedures of paraffin embedded brains. Here, the usage of a recombinant MV (MV-EGFP-CAMH) expressing the haemagglutinin (H) of the rodent-adapted MV-strain CAM/RB and the enhanced green fluorescent protein (EGFP) is described. In newborn rodents the virus infects neurons and causes an acute lethal encephalitis. From 2 weeks on, when the immune system of the genetically unmodified animal is maturating, intracerebral (i.c.) infection is overcome subclinically, however, a focal persistent infection in groups of neurons remains. The complete brain can be analysed in 50 or 100 microm slices, and infected autofluorescent cells are readily detected. Seven and 28 days post-infection (p.i.) 86 and 81% of mice are infected, respectively, and virus persists for more than 50 days p.i. Intraperitoneal immunization with MV 1 week before infection, but not after infection, protects and prevents persistence. The high percentage of persistence demonstrates that this is a reliable and useful model of a persistent CNS infection in fully immunocompetent mice, which allows the investigation of determinants of the immune system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760404     DOI: 10.1099/vir.0.81838-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Disease duration determines canine distemper virus neurovirulence.

Authors:  François Bonami; Penny A Rudd; Veronika von Messling
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

2.  What Kaplan-Meier survival curves don't tell us about CNS disease.

Authors:  Katelyn D Miller; Glenn F Rall
Journal:  J Neuroimmunol       Date:  2017-02-03       Impact factor: 3.478

3.  Impaired cholesterol biosynthesis in a neuronal cell line persistently infected with measles virus.

Authors:  Shahar Robinzon; Avis Dafa-Berger; Mathew D Dyer; Bryan Paeper; Sean C Proll; Thomas H Teal; Slava Rom; Daniel Fishman; Bracha Rager-Zisman; Michael G Katze
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

4.  Characteristics of viruses derived from nude mice with persistent measles virus infection.

Authors:  Yusaku Abe; Koichi Hashimoto; Masahiro Watanabe; Shinichiro Ohara; Masatoki Sato; Yukihiko Kawasaki; Yuko Hashimoto; Mitsuaki Hosoya
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

5.  Major histocompatibility complex haplotype determines hsp70-dependent protection against measles virus neurovirulence.

Authors:  Thomas Carsillo; Mary Carsillo; Zachary Traylor; Päivi Rajala-Schultz; Phillip Popovich; Stefan Niewiesk; Michael Oglesbee
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

Review 6.  Making it to the synapse: measles virus spread in and among neurons.

Authors:  V A Young; G F Rall
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

7.  Clearance of measles virus from persistently infected cells by short hairpin RNA.

Authors:  Michael Zinke; Sabine Kendl; Katrin Singethan; Markus Fehrholz; Dajana Reuter; Linda Rennick; Marco J Herold; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

Review 8.  Measles virus infection of the CNS: human disease, animal models, and approaches to therapy.

Authors:  Dajana Reuter; Jürgen Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 4.148

Review 9.  Blue moon neurovirology: the merits of studying rare CNS diseases of viral origin.

Authors:  Lauren A O'Donnell; Glenn F Rall
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-24       Impact factor: 7.285

10.  Foxp3+ regulatory T cells control persistence of viral CNS infection.

Authors:  Dajana Reuter; Tim Sparwasser; Thomas Hünig; Jürgen Schneider-Schaulies
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.